Hungary issues EU certification to China's Sinopharm vaccine
CGTN, 03 Apr 2021
For more:
https://www.cgtn.com/video
The China National Pharmaceutical Group Co., Ltd. (Sinopharm) announced on Saturday that its COVID-19 vaccine has acquired the certificate of Good Manufacturing Practice (GMP) issued by the Hungarian National Institute of Pharmacy and Nutrition (OGYEI). China's Sinopharm COVID-19 vaccine is the first Chinese vaccine authorized for emergency use by the European Union and the first to be certified by OGYEI, according to a company statement.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
https://www.cgtn.com/video
The China National Pharmaceutical Group Co., Ltd. (Sinopharm) announced on Saturday that its COVID-19 vaccine has acquired the certificate of Good Manufacturing Practice (GMP) issued by the Hungarian National Institute of Pharmacy and Nutrition (OGYEI). China's Sinopharm COVID-19 vaccine is the first Chinese vaccine authorized for emergency use by the European Union and the first to be certified by OGYEI, according to a company statement.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
